Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 2 | Rare Historical Photos

'Pharma Bro' Martin Shkreli Tells Critics 'Do Not Make Fun of Me' As Opendoor Short Sours Amid Rate-Cut Rally: 'That Is Inappropriate'

Investor Martin Shkreli, popularly known as “Pharma Bro,” pushed back against criticism on this recent short position on iBuying platform Opendoor Technologies Inc. (NASDAQ:OPEN), which is rallying amid the Federal Reserve’s rate cuts on Wednesday.

Benzinga

Jim Cramer Pushes For 'Gone Meme' Stock List As Opendoor Surges, Suggests IonQ's Meme Moment Is Over

CNBC's Jim Cramer called for the creation of a "gone meme list" in a post on the social media platform X on Wednesday, suggesting a need to track companies whose speculative trading frenzy has concluded.

Benzinga

Pharma Bro Martin Shkreli Confirms Shorting Opendoor, Plans Public Due Diligence Campaign Into The Firm: 'I Shorted $OPEN'

Martin Shkreli, also popularly known as ‘Pharma Bro,’ announced late Tuesday that he has taken a short position against iBuying real estate company Opendoor Technologies Inc. (NASDAQ:OPEN).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Anthony Pompliano Says Open Naysayers Should Note New CEO Takes Home $1 Token Pay, Martin Shkreli Counters Company 'Fundamentally Broken'

iBuying platform Opendoor Technologies Inc. (NASDAQ:OPEN) has appointed Kaz Nejatian as its new CEO, who previously served as the COO of Shopify Inc. (NASDAQ:SHOP). His illustrious background and new shareholder-aligned compensation package are being hailed by analysts, investors and even critics alike.

Benzinga

Martin Shkreli Doubles Down On Opendoor 'Short' Call: 'Pharma-Bro' Draws Parallels With Newegg — 'Game Over Losers'

Former hedge fund manager and pharmaceutical executive, Martin Shkreli, doubled down on his bearish stance against Opendoor Technologies Inc. (NASDAQ:OPEN), drawing parallels with another retail favorite stock that has since witnessed a pullback.

Benzinga

Martin Shkreli Is Fighting the Short Squeeze in Newegg Stock. How Should You Play NEGG Here?

The controversial former pharmaceutical executive has declared the stock to be a dud.

Barchart

'Pharma Bro' CEO Jacked Price of A Life-Saving Drug From $13.50 to $750 Per Pill Overnight — And His Reason? 'We Needed to Turn a Profit'

Imagine needing a medication that costs less than a fast-food meal—only to wake up the next day and find it's suddenly priced like a luxury car payment…per single pill.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

'Pharma Bro' Martin Shkreli Bets Against Soaring Newegg, But Stock Keeps Climbing

Newegg Commerce Inc. (NASDAQ:NEGG) shares skyrocketed over 22% in Wednesday’s session, extending a volatile run that has seen the stock swing dramatically this year. The surge came as the company expanded its stock sale program, addressed issues tied to a shareholder loan foreclosure, and added its chief executive to the…

Benzinga

'Pharma Bro' Martin Shkreli Shorts Newegg After 1,338% Rally, Calls It 'Close to Worthless'

Former hedge fund manager Martin Shkreli announced on Thursday that he has shorted Newegg Commerce Inc. (NASDAQ:NEGG) following the e-commerce retailer’s massive 1,338% surge this year, dismissing the company as fundamentally overvalued.

Benzinga

Martin Shkreli Is Shorting This ‘Strong Buy’ Penny Stock. How Should You Play Shares Here?

Martin Shkreli says aTyr stock could crash as much as 80% within the next six weeks. ATYR shares are not particularly attractive even without his warning.

Barchart

Palantir Touches New All-Time High Before Fading After Hours: What's Going On?

Shares of Palantir Technologies Inc. (NASDAQ:PLTR) surged to a fresh all-time high, despite there being no company-specific news to lead the session.

Benzinga

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.

Benzinga

Trump fires Democratic FTC commissioners Slaughter, Bedoya - Roll Call

Rebecca Kelly Slaughter and Alvaro Bedoya, the two Democrats on the Federal Trade Commission, said they were 'illegally' fired Tuesday.

Roll Call

Controversial Martin Shkreli Says IONQ and RGTI Stocks Could Be ‘Best Shorts’: Should You Buy or Sell These Quantum Computing Names Now?

Shkreli has sparked a debate about the valuations and technological capabilities of these quantum computing leaders amidst a promising long-term outlook for the industry.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

First Thing: More than 1,400 firefighters tackle ‘unprecedented’ California fires

Tens of thousands of people evacuated in southern California as winds whip blazes. Plus, the rise in ‘flaking’ out of social plans

Barchart

MicroStrategy Stock Alert: Is MSTR ‘Doomed’ for Liquidation?

Martin Shkreli has taken aim at Michael Saylor, warning the MicroStrategy exec that his company could be headed for failure.

Benzinga

Benzinga Bulls And Bears: Amazon, Tesla, Rivian, Palantir And How Dogecoin Helped Low-Income Families Achieve Homeownership

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

Benzinga

'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update

Pharma bro Martin Shkreli predicted Cassava Sciences stock would fall and the company would miss primary endpoints for its Phase 3 trial.

Get all your
news in one place.

100's of premium titles.
One news app.

Louder

“Do you know how many blowjobs that album got me?” Disgraced 'pharma-bro' and ex-emo record label investor Martin Shkreli must tell US court how many copies of Wu-Tang Clan’s singular Once Upon a Time in Shaolin album he made and distributed

Judge orders Martin Shkreli to testify as to how many copies of one-off Wu Tang Clan album he purchased in 2015 might now be in circulation

Fortune

Convicted FTX exec announces his ‘new role’ at Maryland prison on LinkedIn

Ryan Salame announced he was moving on from the fraudulent crypto exchange to his next challenge at a Maryland federal penitentiary.

The Independent UK

Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug

International Business Times

'Pharma Bro' Martin Shkreli Ordered To Surrender All Copies Of Unreleased Wu-Tang Clan Album

The owners of 'Once Upon a Time in Shaolin,' who paid $4.75 million for it, allege he distributed duplicates to his social media followers.

The Guardian - AU

Afternoon Update: Greens MP fronts CFMEU protests; UN chief’s climate SOS; and the website trolling Trump supporters

More than 10,000 workers take to the streets around Australia in protest against the federal takeover of the CFMEU

The Independent UK

‘Pharma bro’ Martin Shkreli ordered to turn over all copies of unreleased Wu-Tang Clan album

‘Pharma Bro’ Martin Shkreli has been ordered to turn over copies of Wu-Tang Clan's unreleased ‘Once Upon a Time in Shaolin’ album to his lawyers by Friday

International Business Times

'Pharma Bro' Whom Trump Called 'Spoiled Brat' Claims He Created $DJT; Token Plunges

The memecoin that saw its popularity spike Monday after being rumored to be the official Donald Trump token, has now started falling from its one-day glory.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.